Efficacy of Hyaluronic Acid Injection in Knee Osteoarthritis

PHASE4RecruitingINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

February 10, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

June 30, 2025

Conditions
Knee OsteoarthritisPain, JointStiffness of Knee, Not Elsewhere ClassifiedQuality of Life
Interventions
DRUG

Sodium Hyaluronate

Sodium hyaluronate 2% (40 mg/2 mL), with molecular weight of 1-2 million dalton Other active ingredient : Mannitol 0.5% Preparation : Pre-filled syringe

DRUG

Normal Saline

0.9% sodium chloride 2 mL prepared in plastic syringe

DRUG

Triamcinolone Acetonide 10mg/mL

10 mg of triamcinolone acetonide will be injected to all participants before the specified intervention

Trial Locations (1)

10400

RECRUITING

Phramongkutklao Hospital, Bangkok

All Listed Sponsors
collaborator

Chulalongkorn University

OTHER

collaborator

Khon Kaen University

OTHER

collaborator

Police General Hospital

OTHER

lead

Phramongkutklao College of Medicine and Hospital

OTHER